MCK vs XOMAP · P/E 20, rev $403.43B vs P/E 25, rev $28.5M
McKesson Corporation (MCK) versus XOMA Royalty Corporation (XOMAP) — a side-by-side from cached financials, not a winner call.
McKesson Corporation (MCK) is a medical distribution company listed on NYSE.
XOMA Royalty Corporation (XOMAP) is a biotechnology company listed on NASDAQ.
Latest reported MCK revenue for 2026-03-31 was $403.43B. Net income was $4.76B. Revenue was up 12.4% from 2025-03-31 to 2026-03-31. MCK currently screens at market cap $91.30B and trailing P/E 20.3.
Latest reported XOMAP revenue for 2024-12-31 was $28.5M. Net income was -$13.8M. Revenue was up 498.7% from 2023-12-31 to 2024-12-31. XOMAP currently screens at market cap $0 and trailing P/E 25.4.
MCK currently screens at market cap $91.30B and trailing P/E 20.3. XOMAP currently screens at market cap $0 and trailing P/E 25.4.
Not investment advice. Open the MCK and XOMAP stock pages for the full models.
Not investment advice.